Literature DB >> 14996188

In vivo PLT increments after transfusions of WBC-reduced PLT concentrates stored for up to 7 days.

M J Dijkstra-Tiekstra1, R N I Pietersz, E C M Hendriks, H W Reesink, P C Huijgens.   

Abstract

BACKGROUND: Bacterial screening and improvement of storage conditions of leukoreduced PLT concentrates (LR-PCs) allows extension of their storage period from 5 to 7 days. STUDY DESIGN AND METHODS: For in vitro studies, 40 LR-PCs made from five buffy coats and plasma were studied for 8 days. For in vivo studies, routinely produced LR-PCs stored for 2 to 7 days after blood collection were administered to clinically stable thrombocytopenic patients. CI1 h was calculated after 353 transfusions (67 patients), and CCI1 h, after 195 transfusions (55 patients), with pretransfusion PLT counts of not greater than 20 x 10(9) per mL.
RESULTS: Storage experiments showed that the pH of LR-PCs remained greater than 6.8 for 8 days, provided that the PLT concentration was less than 1.3 x 10(9) per mL. Routinely produced LR-PCs had a volume of 282 +/- 15 mL (n = 10,193) and contained 329 x 10(9)+/- 40 x 10(9) PLTs (n = 3467). For 7-day-old LR-PCs, 76 of 78 (97%) of the transfusions resulted in a CI1 h of at least 10 and 37 of 39 (95%) in a CCI1 h of at least 7.5, which indicated levels for successfulness. Mean +/- SE values of CI1 h and CCI1 h of 7-day-old LR-PCs were 28.7 +/- 2.3 (n = 78) and 19.0 +/- 2.0 (n = 39), respectively. No significant differences were observed between 5- and 7-day-old LR-PCs transfused with respect to CI1 h and CCI1 h values.
CONCLUSION: In vitro and in vivo studies showed that LR-PCs can be stored for up to 7 days with excellent clinical results, provided that they are routinely screened for bacterial contamination.

Entities:  

Mesh:

Year:  2004        PMID: 14996188     DOI: 10.1111/j.1537-2995.2003.00622.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

1.  10 Years Experience with Bacterial Screening of Platelet Concentrates in the Netherlands.

Authors:  Dirk de Korte
Journal:  Transfus Med Hemother       Date:  2011-07-08       Impact factor: 3.747

2.  A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial.

Authors:  Paula F Ypma; Pieter F van der Meer; Nancy M Heddle; Joost A van Hilten; Theo Stijnen; Rutger A Middelburg; Tor Hervig; Johanna G van der Bom; Anneke Brand; Jean-Louis H Kerkhoffs
Journal:  BMJ Open       Date:  2016-01-27       Impact factor: 2.692

3.  Platelet storage duration and its clinical and transfusion outcomes: a systematic review.

Authors:  Cécile Aubron; Andrew W J Flint; Yves Ozier; Zoe McQuilten
Journal:  Crit Care       Date:  2018-08-05       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.